PortfoliosLab logo

Aerovate Therapeutics, Inc. (AVTE)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS0080641071
CUSIP008064107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$15.15
Year Range$8.25 - $22.83
EMA (50)$13.00
EMA (200)$13.61
Average Volume$72.30K
Market Capitalization$369.82M

AVTEShare Price Chart


Chart placeholderClick Calculate to get results

AVTEPerformance

The chart shows the growth of $10,000 invested in Aerovate Therapeutics, Inc. on Jul 1, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,636 for a total return of roughly -33.64%. All prices are adjusted for splits and dividends.


AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

AVTEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M19.20%-6.21%
YTD28.50%-18.17%
6M45.95%-17.47%
1Y-33.64%-9.25%
5YN/AN/A
10YN/AN/A

AVTEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AVTESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.


Chart placeholderNot enough data

AVTEDividend History


Aerovate Therapeutics, Inc. doesn't pay dividends

AVTEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

AVTEWorst Drawdowns

The table below shows the maximum drawdowns of the Aerovate Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aerovate Therapeutics, Inc. is 63.86%, recorded on Jan 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-63.86%Jul 1, 2021142Jan 21, 2022

AVTEVolatility Chart

Current Aerovate Therapeutics, Inc. volatility is 127.11%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Aerovate Therapeutics, Inc.


Loading data...